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2010 had distinct random amplifi ed 
patterns that differed from those 
generated from isolates A–G (Figure).
A previous study in Taiwan showed 
that the incidence (no. cases/100,000 
inpatients and outpatients) of all 
pulmonary disease caused by NTM 
increased signifi cantly from 2.7 (1.26) 
in 2000 to 10.2 (7.94) in 2008 (6). The 
most common organism in localized 
pulmonary infection and disseminated 
infection was Mycobacteriam avium 
cellular complex, and M. abscessus 
predominated in skin and soft tissue 
infection and lymphadenitis (6,8). 
The rise in pulmonary infections 
or colonization by NTM over 
recent decades, particularly among 
immunocompromised populations, 
is reported to be partly associated 
with the increased use of showers 
(3–5,9). Recently, a few studies have 
shown a link between pulmonary M. 
avium complex infections and home 
showerhead water microbiology (3,4). 
Although pulmonary disease caused 
by M. abscessus did not develop in 
the patient reported here, multiple 
respiratory specimens showed 
evidence of pulmonary colonization. 
The fact that cultures of the swabs 
taken from the interior surface of 4 
showerheads were positive for M. 
abscessus but that cultures of the 
shower water were negative for the 
organism support previous fi ndings 
that assemblages of NTM can occur 
inside biofi lm that forms on the interior 
surface of showerheads (5). The same 
strains of M. abscessus isolated from 
different showerheads suggested 
the possibility of contamination in 
the environment by the aerosolized 
microorganism from respiratory 
secretions of the patient.
The mechanisms of susceptibility 
to mycobacterial infection in the 
patient with Sjögren’s syndrome 
remain unknown (1,2). Previous 
studies suggest that toll-like receptor 
2, dectin-1, tumor necrosis factor–α, 
interferon-γ, leptin, T-cells, and 
possibly neutrophils are major 
components in the host defense of 
HIV-noninfected patients against 
rapidly growing mycobacterial 
infections, including those caused by 
M. abscessus (10).
In summary, we report a case 
of bacteremic lymphadenitis caused 
by M. abscessus in a patient with 
Sjögren syndrome. Our data provide 
evidence that the interior surface of 
showerheads may serve as a source 
of infection by this waterborne and 
aerosolized microorganism.  
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To the Editor: Corynebacterium 
diphtheriae is the agent of pharyngeal 
and cutaneous diphtheria. We did 
a retrospective analysis of the 
antimicrobial drug susceptibilities 
of 46 C. diphtheriae isolates sent 
during 1993 through 2010 to the 
French National Reference Centre 
of Toxigenic Corynebacteria. The 
isolates came from metropolitan 
France and French overseas 
departments and territories. Only 1 
isolate, C. diphtheriae biovar mitis, 
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FRC24, expressed the following anti-
microbial drug susceptibility profi le: 
susceptible to penicillin, amoxicillin, 
ciprofl oxacin, clindamycin, erythro-
mycin, gentamicin, imipenem, 
kanamycin, rifampin, tetracycline, 
and vancomycin and resistant 
at an uncommonly high level 
to trimethoprim, sulfamethoxazole, 
and co-trimoxazole with Etest 
(bioMérieux, Marcy l’Etoile, France) 
MICs of >32, >1,024, and >32 mg/L, 
respectively. 
This FRC24 isolate was isolated 
in 2008 from a cutaneous wound on 
a vaccinated 11-month-old child in 
Mayotte, an overseas department 
located in the Indian Ocean. Cutaneous 
carriage of C. diphtheriae is frequent 
in tropical countries where cutaneous 
diphtheria is endemic; cutaneous 
carriage represents a common mode of 
transmission of the bacterium. FRC24 
was identifi ed by using the API 
Coryne strip (bioMérieux). FRC24 
is a toxigenic isolate; toxigenicity 
was confi rmed by both tox gene 
detection and Elek test (1). Multilocus 
sequence typing was performed, and 
the sequence type (ST) of the isolate 
is ST91. This ST contains only this 
isolate and is part of lineage II, as are 
all mitis and gravis biovars (2).
To date, resistance to 
trimethoprim, sulfamethoxazole, 
or co-trimoxazole seems to be rare 
among the C. diphtheriae species, 
but few data are available (3). As 
trimethoprim resistance is often 
encoded by integron-driven dfr 
determinants, we looked for integrons. 
Integrons are bacterial genetic 
elements able to capture and express 
antimicrobial drug resistance gene 
cassettes (GCs) (4). GC movements 
are catalyzed by an integron-
encoded integrase IntI. GCs, mainly 
promoterless, are usually expressed 
through a common Pc promoter (5). 
Only rare GCs contain their own 
promoter (cmlA, qac, ereA1). Three 
main classes of integrons have been 
described and are involved in the 
dissemination of antimicrobial drug 
resistance; class 1 is the most widely 
found in clinical isolates. Integrons 
have been mainly described among 
gram-negative bacteria; only a few 
studies have reported integrons in 
Corynebacterium spp. (6,7).
After bacterial genomic DNA 
extraction (DNeasy Blood & 
Tissue Kit; QIAGEN, Courtaboeuf, 
France), a multiplex Taqman-based 
quantitative PCR approach able to 
detect the 3 main classes of integrons 
was performed (8). We found that 
FRC24 harbored a class 1 integron. 
Analysis of the GC array showed that 
this integron harbored 2 GCs: dfrA16 
of 588 bp conferring resistance to 
trimethoprim and qacH of 511 bp 
conferring resistance to quaternary 
ammonium compounds (GenBank 
accession no. FR822749). To our 
knowledge, this GC array has not 
been previously reported, even among 
reports of other gram-negative isolates. 
Moreover, a qac determinant has been 
found only once in a Corynebacterium 
species, C. pseudogenitalium 
(which harbors a qacH variant in the 
chromosome [GenBank accession 
no. ABYQ02000013]), but not in 
an integron background. GC arrays 
were followed by the qacEΔ1 (which 
also confers resistance to quaternary 
ammonium compounds), sul1 
(resistance to sulfamethoxazole), 
and orf5 determinants as found in 
most class 1 integrons (4). In class 1 
integrons, 13 Pc variants have been 
described (5). In the FRC24 integron, 
the dfrA16 expression was mediated 
through a strong Pc variant (PcWTGN-10) 
(5) that enables the high-level 
resistance observed for trimethoprim. 
As previously demonstrated, the qacH 
GC possessed its own promoter (9). 
Trimethoprim is a commonly 
prescribed antimicrobial agent 
used in combination with sulfa-
methoxazole (co-trimoxazole) for 
the treatment of diarrheal diseases. 
This antimicrobial drug might have 
selected the emergence of such 
a strain expressing trimethoprim 
resistance. Furthermore, the FRC24 
integron contains the antiseptic 
(quaternary ammonium compounds) 
resistance gene qacH. As cutaneous 
carriage of C. diphtheriae is frequent 
in tropical countries such as Mayotte, 
this bacterium could be exposed to 
quaternary ammonium compounds 
contained in disinfectants, hygienic 
hand washes, and cosmetic products. 
These products exert a selective 
pressure, which might play a 
role in selecting qac-containing 
strains, as has been suggested for 
Staphylococcus spp. (10). For 
staphylococci, the MICs of quaternary 
ammonium compounds are >2 mg/L. 
With FRC24, we tested for the 
MIC of cetyltrimethylammmonium 
bromide and found a MIC of 4 mg/L, 
suggesting that qacH is expressed in 
FRC24.
The sequencing of the genetic 
environment of this integron 
showed that it was framed by 2 
copies of the insertion sequence 
IS6100 disrupting at the left-hand 
side the intI1 integrase gene (online 
Appendix Figure, wwwnc.cdc.gov/
EID/article/17/11/11-0282-FA1.htm). 
IS6100 has been described in a wide 
spectrum of host organisms, including 
Corynebacterium spp. (6,7), thus 
enabling this integron to be effi ciently 
transferred to various bacteria.
Our fi ndings show that C. 
diphtheriae is able to harbor integrons, 
which is of clinical relevance. Indeed, 
this genetic feature would give 
the isolates the capacity to easily 
acquire new GCs, such as ere GCs 
encoding resistance to erythromycin, 
which is one of the antimicrobial 
drugs recommended for diphtheria 
treatment. 
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Syphilis in Teaching 
Hospital, Ghana
To the Editor: Transfusion-
transmitted syphilis, which is caused 
by Treponema pallidum subspecies 
pallidum, is one of the oldest recognized 
infectious risks of blood transfusion (1). 
Routine screening of blood donors and 
refrigeration of donated blood before 
its use has resulted in only 3 reported 
cases of transfusion-transmitted 
syphilis over the past 4 decades (2–6).
The World Health Organization 
recommends screening all donated 
blood for syphilis (7), but doing so 
is challenging for many developing 
countries. Many blood banks in low-
income countries, including Komfo 
Anokye Teaching Hospital in Kumasi, 
Ghana, do not screen donated blood 
for syphilis. 
This study was conducted at 
Komfo Anokye Teaching Hospital. 
The purpose of this study was to 
determine the prevalence of syphilis 
among blood donors and whether 
seroconversion occurred in transfusion 
recipients. The study was approved 
by the ethics committees in Kumasi, 
Ghana, and Liverpool, UK.
Pretransfusion plasma samples 
from 200 conscious transfusion 
recipients in adult, pediatric, and 
obstetric inpatient departments and 
samples of their transfused blood 
were tested for syphilis. A positive 
initial result by enzyme immunoassay 
(EIA) (Bioelisa Syphilis 3.0; Biokit, 
Barcelona, Spain) was confi rmed by 
using a T. pallidum hemagglutination 
assay (TPHA) (Syphagen; Biokit). 
A rapid plasma reagin (RPR) assay 
(RPR Reditest; Biokit) was used to 
determine whether seropositivity 
was caused by recent infection. 
Seronegative recipients who had 
received seropositive blood were 
retested 30 days posttransfusion to 
identify seroconversions. All donors 
and recipients with recent infections 
were offered counseling and treatment 
in accordance with national guidelines.
A total of 145 (73%) blood donors 
were male, and 109 (57%) units of 
blood had been stored for <4 days. 
Sixteen units (8%, 95% confi dence 
interval [CI] 4.3%–11.7%) were 
seropositive for syphilis by EIA and 
TPHA. Of these units, 7 (44%) were 
RPR reactive, which indicated a 
prevalence of recent infections of 3.5% 
(95% CI 1.0%–6.0%) (Table). Twenty-
six transfusion recipients (13%; 95% 
CI 8.3%–17.7%) were seropositive by 
EIA and TPHA. Of these recipients, 
blood samples from 9 (35%) were 
RPR reactive, indicating a prevalence 
of recent infection of 4.5%.
One recipient, an 8-year-old girl 
with severe malarial anemia (recipient 
10), showed seroconversion after 
receiving an RPR-reactive unit of 
blood that had been refrigerated for 
only 1 day before being issued for 
2080 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 17, No. 11, November 2011
